Cargando…

A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study

Phenotypic plasticity, the ability of a living organism to respond to the environment, can lead to conclusions from experiments that are idiosyncratic to a particular environment. The level of environmental responsiveness can result in difficulties in reproducing studies from the same institute with...

Descripción completa

Detalles Bibliográficos
Autores principales: Karp, Natasha A., Wilson, Zena, Stalker, Eve, Mooney, Lorraine, Lazic, Stanley E., Zhang, Bairu, Hardaker, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148295/
https://www.ncbi.nlm.nih.gov/pubmed/32277094
http://dx.doi.org/10.1038/s41598-020-62509-7
_version_ 1783520563951566848
author Karp, Natasha A.
Wilson, Zena
Stalker, Eve
Mooney, Lorraine
Lazic, Stanley E.
Zhang, Bairu
Hardaker, Elizabeth
author_facet Karp, Natasha A.
Wilson, Zena
Stalker, Eve
Mooney, Lorraine
Lazic, Stanley E.
Zhang, Bairu
Hardaker, Elizabeth
author_sort Karp, Natasha A.
collection PubMed
description Phenotypic plasticity, the ability of a living organism to respond to the environment, can lead to conclusions from experiments that are idiosyncratic to a particular environment. The level of environmental responsiveness can result in difficulties in reproducing studies from the same institute with the same standardised environment. Here we present a multi-batch approach to in-vivo studies to improve replicability of the results for a defined environment. These multi-batch experiments consist of small independent mini-experiments where the data are combined in an integrated data analysis to appropriately assess the treatment effect after accounting for the structure in the data. We demonstrate the method on two case studies with syngeneic tumour models which are challenging due to high variability both within and between studies. Through simulations and discussions, we explore several data analysis options and the optimum design that balances practical constraints of working with animals versus sensitivity and replicability. Through the increased confidence from the multi-batch design, we reduce the need to replicate the experiment, which can reduce the total number of animals used.
format Online
Article
Text
id pubmed-7148295
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71482952020-04-15 A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study Karp, Natasha A. Wilson, Zena Stalker, Eve Mooney, Lorraine Lazic, Stanley E. Zhang, Bairu Hardaker, Elizabeth Sci Rep Article Phenotypic plasticity, the ability of a living organism to respond to the environment, can lead to conclusions from experiments that are idiosyncratic to a particular environment. The level of environmental responsiveness can result in difficulties in reproducing studies from the same institute with the same standardised environment. Here we present a multi-batch approach to in-vivo studies to improve replicability of the results for a defined environment. These multi-batch experiments consist of small independent mini-experiments where the data are combined in an integrated data analysis to appropriately assess the treatment effect after accounting for the structure in the data. We demonstrate the method on two case studies with syngeneic tumour models which are challenging due to high variability both within and between studies. Through simulations and discussions, we explore several data analysis options and the optimum design that balances practical constraints of working with animals versus sensitivity and replicability. Through the increased confidence from the multi-batch design, we reduce the need to replicate the experiment, which can reduce the total number of animals used. Nature Publishing Group UK 2020-04-10 /pmc/articles/PMC7148295/ /pubmed/32277094 http://dx.doi.org/10.1038/s41598-020-62509-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Karp, Natasha A.
Wilson, Zena
Stalker, Eve
Mooney, Lorraine
Lazic, Stanley E.
Zhang, Bairu
Hardaker, Elizabeth
A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
title A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
title_full A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
title_fullStr A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
title_full_unstemmed A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
title_short A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
title_sort multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148295/
https://www.ncbi.nlm.nih.gov/pubmed/32277094
http://dx.doi.org/10.1038/s41598-020-62509-7
work_keys_str_mv AT karpnatashaa amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT wilsonzena amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT stalkereve amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT mooneylorraine amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT lazicstanleye amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT zhangbairu amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT hardakerelizabeth amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT karpnatashaa multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT wilsonzena multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT stalkereve multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT mooneylorraine multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT lazicstanleye multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT zhangbairu multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy
AT hardakerelizabeth multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy